Telemedicine Follow-up Improves Early Detection of Ovarian Dysfunction After Uterine Artery Embolization: A Retrospective Cohort Study

Objective: Uterine artery embolization (UAE) for fibroids may cause ovarian dysfunction, particularly concerning for reproductive-aged women. This study evaluated whether telemedicine follow-up improves early detection of ovarian complications compared to traditional outpatient care. Methods: This retrospective cohort study analyzed 232 women aged 18-40 who underwent UAE at Fujian Maternity and Child Health Hospital (December 2020-2023). Participants were assigned to WeChat telemedicine platform (n=138) or traditional follow-up (n=94). Primary outcome was early identification of ovarian dysfunction, defined as diminished ovarian reserve (AMH<1.1ng/ml, FSH 10-15IU/L), or subclinical POI (FSH 15-25IU/L). Secondary outcomes included hormone replacement therapy adherence and quality of life scores. Results: Telemedicine significantly improved early detection of ovarian dysfunction (21% vs 3%, p<0.001), particularly in women aged 28-36 (OR=7.84, 95%CI: 1.05-58.44). Follow-up completion increased substantially (3.83±0.60 vs 2.67±1.04 visits, p<0.001). Among patients with confirmed dysfunction, telemedicine achieved superior hormone therapy adherence (82.8% vs 27.3% good adherence, p<0.001) and better quality of life scores at 3 months (MENQOL: 49.83±10.82 vs 59.09±15.30, p=0.038). Conclusion: Telemedicine follow-up after UAE significantly enhances early detection of ovarian dysfunction and treatment adherence. Integration of structured remote monitoring protocols into post-UAE care pathways may improve long-term reproductive health outcomes.